George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.

Ellen A. Ronnen, MD

Dr. Ellen A. Ronnen is board certified in internal medicine, hematology and medical oncology. For more than 6 years, she has been treating patients in the central New Jersey community.

Dr. Ronnen received her medical degree from the Albert Einstein College of Medicine. She completed her residency in internal medicine at New York University Medical Center, where she served as Chief Resident. She conducted her fellowship training in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York, NY.

Dr. Ronnen is a member of the American Society of Clinical Oncology and the Medical Society of New Jersey. During her fellowship, at past meetings of the American Society of Clinical Oncology, Dr. Ronnen presented discussions on metastatic renal cell carcinoma and treatment outcomes for patients with germ cell tumors. She also presented on the treatment of renal cell carcinoma at Memorial Sloan-Kettering Cancer Center. She has been published in multiple peer-reviewed journals such as the Journal of Clinical Oncology, and also has written chapters on renal cell carcinoma and Hodgkin’s disease for Hematology and Oncology Pearls.

Phillip D. Reid, MD

Dr. Phillip D. Reid is board certified in hematology and medical oncology. For more than 12 years, he has been treating patients in the central New Jersey community.

Dr. Reid received his medical degree from the Stanford University School of Medicine. He completed his residency in internal medicine at Harvard Medical School’s Brigham and Women’s Hospital and conducted his fellowship training in oncology and hematology at Harvard Medical School’s Dana-Farber Cancer Institute. He completed a Clinical Effectiveness Course at the Harvard School of Public Health.

Dr. Reid is currently a Clinical Instructor at University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School. He is a member of the American Society of Clinical Oncologists, American Society of Hematology, and Medical Society of New Jersey. While attending Stanford University School of Medicine, he was the recipient of the Stanford Medical Scholar Award and the Pfeiffer Memorial Research Fellowship.

Bruno S. Fang, MD

Board-Certified: Internal Medicine, Medical Oncology, Hematology

“Practicing oncology gives me the opportunity to treat life-threatening diseases, all while developing a close personal relationship with you and your loved ones. While respecting your autonomy and choices, my job is to educate and guide, while forming a partnership for joint decision-making.”

“As opposed to other specialty physicians, oncologists treat you as a whole instead of a problem defined by a specific organ. My broad knowledge of medicine allows me to help you in many aspects of your overall health. Empathy, combined with the understanding of your specific mental, intellectual, and spiritual response to your cancer journey, helps me deliver the highest standard of comprehensive care.”

Fellowship: Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD

Fellowship: Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Residency: Internal Medicine, University of Miami, Jackson Memorial Hospital,
Miami, FL

MD: University of Sao Paulo School of Medicine, Sao Paulo, Brazil

Honors: Named a Top Doctor multiple times by New Jersey Monthly and Inside Jersey; listed in U.S. News & World Report; listed in Top Doctors: New York Metro Area by Castle Connolly Ltd..; Alpha Omega Alpha National Medical Honor Society; Chief Fellow; Chief Fellow, National Cancer Institute; Chief Resident, University of Miami
Teaching Faculty: Robert Wood Johnson University Hospital, New Brunswick, NJ

Languages: English, Portuguese, Spanish

To schedule an appointment with Dr. Fang, visit https://centraljerseyrcca.com.

Michael J. Nissenblatt, MD

Dr. Michael J. Nissenblatt is board certified in internal medicine and medical oncology. For more than 30 years, he has been treating patients in the central New Jersey community. His research interests are in genetics and hereditary cancers, personalized medicine, and the origin of aging and longevity.

Dr. Nissenblatt received his medical degree from the Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha National Medical Honor Society. He completed his residency in internal medicine and fellowship in medical oncology at Johns Hopkins University School of Medicine.

In 1978, Dr. Nissenblatt joined the faculty of UMDNJ — Robert Wood Johnson Medical School as their first full-time oncologist. He is presently a Clinical Professor at the medical school. He is the Associate Director of Oncology and the Cancer Liaison Physician to the American College of Surgery for the Cancer Committee at Robert Wood Johnson University Hospital.

A dedicated volunteer for the American Cancer Society for more than two decades, he has served as its President, perennially leading fundraisers, and Co-Chairman with his wife Marlene for their leading annual fundraising event known as the “Night of Wine and Roses.” Dr. Nissenblatt has founded several charitable organizations, including the Challah Foundation and Partners in Healing, which assists people with cancer who are experiencing financial challenges. Fred’s Team raises funds to fight childhood leukemia, and Dr. Nissenblatt runs the NYC Marathon annually for this Memorial Sloan-Kettering-initiated charity. He is a Past President of the New Jersey Oncology Society and is currently a member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of New Jersey, and Oncology Society of New Jersey. His numerous honors include being named annually as a “Top Doctor” by Inside Jersey, New Jersey Monthly, and New York magazines. He has also been regularly listed in Castle Connolly “Top Doctors” in the New York Metro Area and in U.S. News & World Report.

George I. Karp, MD

Dr. George I. Karp is board certified in internal medicine, hematology and medical oncology. For more than 29 years, he has been treating patients in the central New Jersey community. His research interests are in clinical trials and complex hematologic problems.

Dr. Karp received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at the University of Chicago. He received fellowship training in hematology and oncology at the National Cancer Institute, Harvard Medical School’s Dana-Farber Cancer Institute, and Beth Israel Hospital. While in Boston, he was also a Visiting Scientist at the Massachusetts Institute of Technology and an Instructor at Harvard Medical School.

Dr. Karp holds an appointment as Clinical Professor of Medicine at Robert Wood Johnson Medical School. He is a member of the Executive Committee of the Institutional Review Boards at both University of Medicine and Dentistry of New Jersey (UMDNJ) — Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital. He is an affiliate member of the Cancer Institute of New Jersey, and a member of the American Society of Clinical Oncology and American Society of Hematology. He has been included numerous times in lists of the “Top Doctors” in hematology and oncology by Inside Jersey, New Jersey Monthly and New York magazines, U.S. News & World Report, and Castle Connolly “Top Docs” in the New York Metro Area.

Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.

Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT). He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine. He then completed a fellowship in medical oncology at the Cancer Institute of New Jersey.

Dr. Licitra currently serves as Chairman of the Board of Directors of Regional Cancer Care Associates. He was selected as a “Top Doctor” in oncology and hematology by New Jersey Monthly magazine. While attending Robert Wood Johnson Medical School, he was elected to Alpha Omega Alpha, the National Medical Honor Society. Dr. Licitra was selected as the Department of Internal Medicine Outstanding PGY2 Resident, and was the recipient of the Medical School Research Award. At MIT, he was selected as a Moore and Packard Predoctoral Fellow. He is currently a member of the American Society of Clinical Oncology and the Medical Society of New Jersey.